Join us at Abu Dhabi Future Health Summit 20-22 October 2026

Impact Areas

Longevity & Precision Health

Longevity and precision medicine focus on extending healthy life expectancy by understanding biological processes at an individual level and enabling earlier, more personalized interventions. This matters because advances in science and care create a growing opportunity to align gains in lifespan with gains in health span, supporting longer lives that are healthier, more functional, and more resilient. A life-course perspective further extends this opportunity by positioning precision medicine as a lifelong approach, from early development and adolescence through ageing, shaping health trajectories well before disease emerges.

Our whitepaper, The Future of Longevity: Extending Healthspan: How Abu Dhabi is building a longevity-first health ecosystem, developed in collaboration with EY, explores how health systems can evolve from managing disease to maintaining health, bringing together advances in precision medicine, prevention, research, technology and investment.

Where the science stands:

Research in genomics and multi-omics integration is rapidly improving the ability to detect biological changes associated with ageing and disease before clinical symptoms appear. Studies combining genomic, transcriptomic, proteomic, and metabolomic data demonstrate improved risk prediction and earlier identification of disease pathways. Single-cell and longitudinal analyses are refining measures of biological age, supporting a shift from population averages toward individualized health trajectories.

Opportunities

Translate validated biomarkers into preventive and personalized care

Guide earlier, targeted interventions across the life course to delay or prevent disease

Improve efficiency and outcomes by reducing late-stage treatment reliance

Key challenges

High cost and complexity of multi-omics technologies

Limited standardization and clinical validation pathways

Integration of complex biological data into routine care

Digital Health & AI

Digital health and Artificial Intelligence enable continuous sensing, analysis, and guidance across the health journey. This matters because connected technologies and advanced analytics can support earlier insights, more responsive care, and better health outcomes at scale. Strong governance, ethical oversight, and transparent stewardship are essential to ensure that predictive technologies build trust, protect rights, and distribute benefits equitably.

Where the science stands:

Current research shows expanding application of AI in diagnostics, clinical decision support, and population health forecasting. Wearables, remote monitoring, and digital platforms increasingly capture real-time physiological and behavioral data. Studies indicate that AI systems can support clinical performance in defined tasks when combined with professional oversight and high-quality data.

Opportunities

Enable proactive risk prediction and early intervention

Scale remote and hybrid care models

Improve system efficiency through data-driven decision support

Key challenges

Data privacy, security, and governance requirements

Risk of algorithmic bias and lack of transparency

Ensuring fair access and accountability in AI-driven decision making

Health System Resilience & Sustainability

Health system resilience and sustainability refer to the capacity of health systems to anticipate change, adapt to emerging risks, and maintain essential services over time. This matters because resilient systems are better positioned to protect populations, manage uncertainty, and sustain health gains in a changing global environment. Resilience increasingly depends on integrating behavioral, cognitive, and cultural dimensions of health, as well as environmental and planetary signals, into a more holistic understanding of population well-being.

Where the science stands:

Research highlights the importance of integrated surveillance, environmental and exposure monitoring, and continuous diagnostic readiness. Global health organizations emphasize combining clinical, environmental, social, and behavioral data to support preparedness and adaptive response. Post-pandemic analyses reinforce the value of flexible workforces, interoperable data systems, and cross-sector coordination.

Opportunities

Embed predictive analytics into preparedness and system planning to improve timely access to essential services

Strengthen early warning and response mechanisms across health and environmental domains, including underserved and high-risk populations

Build workforce models and new health roles that support adaptive, data-enabled care delivery across diverse settings and resource levels

Key challenges

Fragmented data and infrastructure that limit continuity of care and equitable access

Workforce capacity constraints and skills mismatches, particularly in primary care and low-resource contexts

Difficulty translating multi-source sensing into timely operational action that reaches all populations, not only those already well served

Invest in Life Sciences

Investment in life sciences enables the translation of scientific discovery into scalable tools, technologies, and solutions that improve health outcomes. This matters because sustained and strategic investment is essential to move innovations from research into real-world use, support earlier detection and prevention, and ensure that advances in health science deliver broad and lasting impact.

Where the science stands:

Recent investment trends show growing interest in precision diagnostics, AI-enabled discovery, and platforms that integrate biological data with real-world evidence. Public, private, and philanthropic capital play a critical role in expanding equitable access to these technologies by supporting innovations that accelerate research, shorten development timelines, and enable earlier and more effective intervention.

Opportunities

Accelerate translation from scientific discovery to real-world health impact

Support integrated data, research, and innovation ecosystems

Enable broader and more equitable access to high-impact diagnostics and technologies by catalyzing collaboration across public, private, and philanthropic sectors

Key challenges

Regulatory complexity and lengthy development and approval processes vs speed of innovation

Uneven access to capital, infrastructure, and innovation capacity across regions

Misalignment between investment incentives and long-term preventive health outcomes

Meet the Winners of the Future Health Challenge 2026

Winning teams were recognised from the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve.

Their solutions address critical challenges in early detection, continuous population insight, and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention.

The Future Health Challenge is part of a year-round programme of activities designed to identify and champion high-potential talent globally, and connect innovators with funding, partnerships and pathways to scale solutions that advance longer, healthier lives.